Moffitt Cancer Center has maintained a focused effort to increase the number of investigator-initiated early phase clinical studies. In 2010, investigators at Moffitt Cancer Center enrolled 354 patients on phase I or l/ll studies. Moffitt remains focused on investigator-initiated studies as a high priority. Services include protocol initiation, activation, coordination and administration, as well as coordination of study-related patient care and data collection. More specifically, the duties and functions of the clinical research coordinators, requested for this Protocol-Specific Research Support Core Facility, will be to coordinate phase I and pilot study clinical trials, including assisting with determining patient eligibility and registration and coordinating protocol-related care of patients enrolled on clinical studies. The research coordinator ensures completion of patient assessments for adverse event and toxicity grading, thorough documentation of all patient observations, and appropriate patient followup according to protocol design. The research coordinator is required to have an in-depth knowledge of protocol requirements and good clinical practices as set forth by Federal regulations. As the primary resource for the protocols, the research nurse/coordinator acts as liaison between investigators, primary care providers, Moffitt regulatory staff, and the sponsor. Along with the investigator, the research coordinator will screen, enroll, and follow study subjects, ensuring protocol compliance and close monitoring while the subjects are on study. The Core requests CCSG Support of $137,864 for support of four research nurses totaling 2 FTEs.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA076292-15
Application #
8495994
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
2013-02-01
Budget End
2014-01-31
Support Year
15
Fiscal Year
2013
Total Cost
$78,699
Indirect Cost
$31,994
Name
H. Lee Moffitt Cancer Center & Research Institute
Department
Type
DUNS #
139301956
City
Tampa
State
FL
Country
United States
Zip Code
33612
Chung, Brile; Stuge, Tor B; Murad, John P et al. (2014) Antigen-specific inhibition of high-avidity T cell target lysis by low-avidity T cells via trogocytosis. Cell Rep 8:871-82
Charbonneau, Bridget; Block, Matthew S; Bamlet, William R et al. (2014) Risk of ovarian cancer and the NF-*B pathway: genetic association with IL1A and TNFSF10. Cancer Res 74:852-61
Unrod, Marina; Simmons, Vani N; Sutton, Steven K et al. (2014) A randomized clinical trial of self-help intervention for smoking cessation: research design, interventions, and baseline data. Contemp Clin Trials 38:284-90
Osorio, Ana; Milne, Roger L; Kuchenbaecker, Karoline et al. (2014) DNA glycosylases involved in base excision repair may be associated with cancer risk in BRCA1 and BRCA2 mutation carriers. PLoS Genet 10:e1004256
Padron, Eric; Yoder, Sean; Kunigal, Sateesh et al. (2014) ETV6 and signaling gene mutations are associated with secondary transformation of myelodysplastic syndromes to chronic myelomonocytic leukemia. Blood 123:3675-7
Hampras, Shalaka S; Viscidi, Raphael P; Helzlsouer, Kathy J et al. (2014) Prospective study of seroreactivity to JC virus T-antigen and risk of colorectal cancers and adenomas. Cancer Epidemiol Biomarkers Prev 23:2591-6
Chen, Ning; Chon, Hye Sook; Xiong, Yin et al. (2014) Human cancer cell line microRNAs associated with in vitro sensitivity to paclitaxel. Oncol Rep 31:376-83
Molife, L Rhoda; Yan, Li; Vitfell-Rasmussen, Joanna et al. (2014) Phase 1 trial of the oral AKT inhibitor MK-2206 plus carboplatin/paclitaxel, docetaxel, or erlotinib in patients with advanced solid tumors. J Hematol Oncol 7:1
Carvalho, Renato S; Fernandes, Vanessa C; Nepomuceno, Thales C et al. (2014) Characterization of LGALS3 (galectin-3) as a player in DNA damage response. Cancer Biol Ther 15:840-50
Rizwani, Wasia; Schaal, Courtney; Kunigal, Sateesh et al. (2014) Mammalian lysine histone demethylase KDM2A regulates E2F1-mediated gene transcription in breast cancer cells. PLoS One 9:e100888

Showing the most recent 10 out of 108 publications